BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

July 10, 1997

View Archived Issues

N-type calcium channel blockers isolated from marine bacterium

Read More

Korean researchers discover new melanin synthesis inhibitors

Read More

Lepetit discovers IL-1RI inhibitors from microbial samples

Read More

Effect of aripiprazole on dopaminergic transmission in striatal neurons

Read More

Kyowa Hakko develops cell adhesion inhibitors

Read More

New lactam compounds for sepsis and RA

Read More

Lupulon for the treatment of MRSA

Read More

Kanebo describes new selectin inhibitors

Read More

Potential role for melatonin in epilepsy therapy?

Read More

Free radical-scavenging activity described for zonisamide

Read More

Lamotrigine shows favorable psychotropic effects in epileptics

Read More

Adverse CNS effects reported for antiepileptic drug

Read More

UCSF scientist complains of regressive tendency in epilepsy therapy

Read More

Novel hemoregulatory compounds from SKB

Read More

Selective alpha1a-adrenoceptor blockers described by Merck & Co.

Read More

Sanwa Kagaku discloses novel selectin inhibitors for inflammatory disorders

Read More

Preclinical data reported for JTP-2942

Read More

Yamanouchi, Ferring collaborate on endothelin antagonists

Read More

MS-818 effective in rat model of nerve degeneration

Read More

Clinical evaluation of FO-726

Read More

Novel approach to epilepsy treatment recommended for approval by FDA panel

Read More

CPC-111 moves toward pivotal trials for bypass surgery

Read More

Further phase II results for Ceresine in head injury

Read More

Exocell presents humanized MAb for diabetic nephropathy

Read More

Preclinical and clinical antidepressant properties of tolcapone

Read More

Nefazodone evaluated for social phobia

Read More

New clinical uses of risperidone investigated

Read More

Role of glutamate antagonists in epilepsy debated

Read More

Hycamtin launched in Canada

Read More

FDA clears Bayer's cholesterol-lowering agent

Read More

Smoking cessation treatment launched in the U.S.

Read More

Future concepts in pain

Read More

SNX-111 and SNX-230, analgesic conopeptides and calcium channel blockers

Read More

Management of peripheral pain using neurotrophins

Read More

NK1 receptor antagonists for pain

Read More

c-fos gene is implicated in pain states

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 13, 2026.
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent

    BioWorld Science
    Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing